ULIHF Revenue

In the year 2024, The United Laboratories International Holdings had annual revenue of 13.76B CNY with 0.14% growth. The United Laboratories International Holdings had revenue of 6.58B in the half year ending December 31, 2024, with 7.00% growth.

Revenue

13.76B CNY

Revenue Growth

+0.14%

P/S Ratio

1.73

Revenue / Employee

809.35K CNY

Employees

17,000

Market Cap

3.27B USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	13.76B	19.06M	0.14%
Dec 31, 2023	13.74B	2.41B	21.22%
Dec 31, 2022	11.33B	1.63B	16.81%
Dec 31, 2021	9.70B	930.95M	10.61%
Dec 31, 2020	8.77B	379.89M	4.53%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
Veradigm	588.02M
Tian'an Technology Group	1.78M
Glass House Brands	200.90M
Elite Pharmaceuticals	70.00M
Northwest Biotherapeutics	1.38M
BioStem Technologies	301.83M
American Oncology Network	1.76B

Revenue Rankings

The United Laboratories International Holdings News

5 weeks ago - Novo Nordisk Strikes $2B Deal for Obesity Drug - Investopedia

More News